A carregar...

Preclinical Development of siRNA Therapeutics for AL Amyloidosis

AL (amyloid light chain) amyloidosis is a rare hematologic disorder characterized by the accumulation of a misfolded monoclonal immunoglobulin light chain (LC) as fibrillar protein deposits. Current treatments, including cytotoxic chemotherapy and immunomodulatory therapy, are directed at killing th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hovey, Beth M., Ward, Jennifer E., Hoo, Pamela Soo, O’Hara, Carl J., Connors, Lawreen H., Seldin, David C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3155733/
https://ncbi.nlm.nih.gov/pubmed/21562591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gt.2011.69
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!